Canadian Start-Ups: Academics Become Entrepreneurs
This article was originally published in Start Up
Executive Summary
By rewarding ownership, Canada is attempting to keep its arms around native technology. Canadian companies are recompensed by R&D tax credits at the federal and provincial levels and individual investors get R&D tax credits for long-term investing in Canadian firms. Recenty, $2 billion in venture funding has come into the life sciences industry. To capture this new funding, entrepreneurs have emerged from academic laboratories, creating more than 200 new biotech companies since 1994.
You may also be interested in...
Replicor Inc.
Spun-out of McGill University, Replicor is modulating DNA replication for better gene therapies and to influence cell proliferation for cancer or tissue engineering.
Viron Therapeutics Inc.
Viron Therapeutics is using proteins derived from pox viruses to develop immunomodulating drugs.
Vaxis Therapeutics Corp.
Vaxis Therapeutics enters a market made popular by {Viagra}: it is developing both oral and local therapies for male and female sexual dysfunction.